Guidant tests intravascular radiotherapy in Japan:
This article was originally published in Clinica
Executive Summary
Guidant claims it has become the first to begin a clinical trial of intravascular radiotherapy in Japan. The Indianapolis, Indiana firm will assess its Galileo intravascular radiotherapy system as a treatment for in-stent restenosis in 75 patients at five Japanese sites. The Galileo system was first CE-marked for sale in Europe last year. Guidant recently gained European approval to sell the device as a treatment for long coronary lesions - as long as 47mm.